U.S. Home Healthcare Top Companies and Strategic Involvement

Top Companies in the U.S. Home Healthcare Market & Their Offerings

What are the Recent Developments in the U.S. Home Healthcare Market? 

• In July 2025, TeleMedCare launched a remote patient monitoring program in partnership with a major U.S. insurance and healthcare provider serving multiple states and over 500,000 members. The pilot project is being conducted in Florida with around 300 patients suffering from chronic conditions such as heart failure, COPD, diabetes, and hypertension. The initiative aims to improve long-term disease management through continuous remote monitoring and early intervention.
• In July 2025, The Pennant Group Inc. acquired GrandCare Health Services, a well-known home health agency, which has been rebranded as GrandCare Home Health. This acquisition expands Pennant’s home healthcare operations across key California counties, including Los Angeles, Orange, Riverside, and San Diego, while also strengthening its existing presence in senior living services in these regions.

Supply Chain Analysis

Clinical Trials

• Clinical trials in the U.S. home healthcare sector are increasingly using decentralized approaches and home-based nursing support, allowing patients to receive treatments and participate in studies from their own homes. This model reduces travel burden, improves patient participation and retention, and enables remote monitoring, medication delivery, and data collection.
• Key players: IQVIA Holdings Inc., ICON plc, and Laboratory Corporation of America Holdings (Labcorp).

Regulatory Approvals

U.S. home healthcare regulation involves two main areas: licensing for care providers and approval of medical devices used at home. Agencies must obtain state-level licenses, meet Medicare/Medicaid certification requirements, and follow CMS standards, while home-use medical devices must be cleared or approved by the FDA. Key players: Centers for Medicare & Medicaid Services, U.S. Food and Drug Administration, McKesson Corporation, Medtronic plc, Baxter International Inc.

Patient Support and Services

• U.S. home healthcare refers to physician-prescribed clinical services delivered at home, including skilled nursing, physical and occupational therapy, and medical social support, aimed at helping homebound patients recover and improve independence. It is different from non-medical home care, which focuses on daily living assistance, companionship, and household support.
• Key players: Amedisys Inc., LHC Group Inc., Kindred at Home.

Market Growth

The U.S. home healthcare market size was estimated at USD 56.93 billion in 2025 and is predicted to increase from USD 61.48 billion in 2026 to approximately USD 122.91 billion by 2035, expanding at a CAGR of 8% from 2026 to 2035.